Carbon-based nanomaterials as potential COVID-19 treatments
An international team of researchers says that carbon-based nanomaterials (CBNs) could represent promising new approaches to treating coronavirus disease 2019 (COVID-19) pneumonia that is complicated by a secondary bacterial, viral or fungal infection.
The team says that CBNs such as fullerene, carbon dots, graphene, and their derivatives could serve as effective alternatives to currently proposed therapies that have demonstrated little clinical effect or become multi-drug resistant.
Ángel Serrano-Aroca from Valencia Catholic University Saint Vincent Martyr in Spain and colleagues reviewed the evidence available so far on the antiviral activity and broad-spectrum antimicrobial properties of CBNs.